Paclitaxel-carboplatin and bevacizumab combination with maintenance bevacizumab therapy for metastatic, recurrent, and persistent uterine cervical cancer: An open-label multicenter phase II trial (JGOG1079)

Autor:	Tanigawa, Terumi, Takeshima, Nobuhiro, Ishikawa, Hideki, Nishio, Shin, Usami, Tomoka, Yamawaki, Takaharu, Oishi, Tetsuro, Ihira, Kei, Kato, Hisamori, Goto, Mayako, Saito, Motoaki, Taira, Yusuke, Yokoyama, Masatoshi, Shoji, Tadahiro, Kondo, Eiji, Mori, Atsushi, Yokoi, Takeshi, Iwasa-Inoue, Naomi, Hirashima, Yasuyuki, Nagasawa, Takayuki, Takenaka, Motoki, Mikami, Mikio, Sugiyama, Toru, Enomoto, Takayuki
Zdroj:	In Gynecologic Oncology June 2022 165(3):413-419
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect